Testing samples for the presence of Covid-19
06. 04. 2020
02. 05. 2020 | 21:46 - 21:46
Scientists from the Institute of Biotechnology of the Academy of Sciences are part of the team of the BIOCEV center, which is led by RNDr. Ruth Tachezy has developed and validated a new reliable SARS-CoV-2 virus detection procedure that allows up to hundreds of samples to be evaluated daily from hospital patients and nursing home clients.
The Gene Core Service Laboratory - Quantitative and Digital PCR and the Biotechnology Institute 's Gene Expression Laboratory have developed qPCR technology, which is used to identify viral RNA and can determine the presence of Covid-19 virus. More than 20 employees participated in the testing at the Institute of Biotechnology, who will test the samples already taken.
Among the employees of the BIOCEV center, 100 volunteers applied, who work with infectious and non-infectious material, with viral RNA and its identification by PCR method, and at the same time provide related administration and logistics. The virological laboratories and research infrastructures of the 1st Medical Faculty of Charles University and the Faculty of Science of Charles University, the Institute of Biotechnology of the CAS and the Institute of Molecular Genetics of the CAS participate in the testing.